GLP-1 Drugs Linked To Better Breast Cancer Outcomes
In a new study, breast cancer patients using GLP-1 medications for obesity and/or diabetes had a lower risk of recurrence and death over 10 years of follow-up.
Health News is provided as a service to The Medicine Shoppe #503 site users by HealthDay. The Medicine Shoppe #503 nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.